European Biotech Acquisition Corp. Units
EBACU
EBACU was delisted on the 2nd of March, 2023.
22 hedge funds and large institutions have $16M invested in European Biotech Acquisition Corp. Units in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 4 closing their positions.
15% less funds holding
Funds holding: 26 → 22 (-4)
31% less capital invested
Capital invested by funds: $23.2M → $16M (-$7.24M)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$43K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.03K |
| 3 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$4.8M |
| 2 |
GCL
Glazer Capital LLC
New York
|
-$2.37M |
| 3 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$1.49M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$108K |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$75.1K |
EBACU Hedge Fund Activity: Q1 2022 in Review
22 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Units (EBACU) for Q1 2022, worth a combined $16M — down 31% from $23.2M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of EBACU and 0 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 3 added.
The largest buyer was Wolverine Asset Management, adding an estimated $43K. The largest seller was Millennium Management, cutting an estimated $4.8M.
- 22 institutional investors held European Biotech Acquisition Corp. Units (EBACU) as of Q1 2022, down from 26 in Q4 2021.
- Funds reported $16M of European Biotech Acquisition Corp. Units stock for Q1 2022, down 31% quarter-over-quarter.
- 0 funds opened new European Biotech Acquisition Corp. Units positions in Q1 2022 and 4 closed out, a net change of -4 holders.
- The largest European Biotech Acquisition Corp. Units buyer in Q1 2022 was Wolverine Asset Management, an estimated $43K added.
- The largest European Biotech Acquisition Corp. Units seller in Q1 2022 was Millennium Management, an estimated $4.8M sold.
Based on aggregated 13F filings for Q1 2022.